1型糖尿病患者因COVID-19住院后重症与死亡风险分析
调整年龄、性别和种族后,T1DM患者较无糖尿病患者ICU/MV绝对风险高21%、死亡绝对风险高5%;较T2DM患者ICU/MV绝对风险高9%,但死亡无差异。进一步调整糖尿病酮症酸中毒(DKA)后,T1DM与T2DM患者ICU/MV风险差异消失。
要点
- T1DM因COVID-19住院者较无糖尿病者ICU/MV和死亡风险均显著升高。
- T1DM较T2DM患者ICU/MV风险更高,但死亡风险无差异。
- DKA可解释T1DM与T2DM之间ICU/MV风险差异的大部分。
核心结论
- T1DM因COVID-19住院患者较无糖尿病患者发生ICU/MV和死亡的风险更高。
- T1DM较T2DM患者ICU/MV风险更高,但该差异主要由DKA解释,调整DKA后死亡风险反而更低。
研究设计与样本
- 采用logistic模型估计T1DM相对于无糖尿病或T2DM患者的ICU/MV和死亡的风险差(RD)与风险比(RR),并逐步调整年龄、性别、种族或民族及额外人口学和临床特征。
主要发现
- 与无糖尿病患者相比,T1DM患者ICU/MV绝对风险高21%(RD 0.21,95%CI 0.19-0.24;RR 1.49,95%CI 1.43-1.56),死亡绝对风险高5%(RD 0.05,95%CI 0.03-0.07;RR 1.40,95%CI 1.24-1.57)。
- 与T2DM患者相比,T1DM患者ICU/MV绝对风险高9%(RD 0.09,95%CI 0.07-0.12;RR 1.17,95%CI 1.12-1.22),但死亡风险无差异(RD 0.00,95%CI -0.02至0.02;RR 1.00,95%CI 0.89-1.13)。
- 调整COVID-19诊断前或诊断时发生的DKA后,T1DM与T2DM患者相比ICU/MV风险无显著差异(RD 0.01,95%CI -0.01至0.03),死亡风险更低(RD -0.03,95%CI -0.05至-0.01)。
临床怎么用
- 对因COVID-19住院的T1DM患者应警惕ICU/MV和死亡风险升高,加强监测与糖尿病管理。
- DKA的发生与T1DM患者ICU/MV风险增加密切相关,预防和及时处理DKA可能改善预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess whether risk of severe outcomes among patients with type 1 diabetes mellitus (T1DM) hospitalized for coronavirus disease 2019 (COVID-19) differs from that of patients without diabetes or with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Using the Premier Healthcare Database Special COVID-19 Release records of patients discharged after COVID-19 hospitalization from U.S. hospitals from March to November 2020 (N = 269,674 after exclusion), we estimated risk differences (RD) and risk ratios (RR) of intensive care unit admission or invasive mechanical ventilation (ICU/MV) and of death among patients with T1DM compared with patients without diabetes or with T2DM. Logistic models were adjusted for age, sex, and race or ethnicity. Models adjusted for additional demographic and clinical characteristics were used to examine whether other factors account for the associations between T1DM and severe COVID-19 outcomes. RESULTS: Compared with patients without diabetes, T1DM was associated with a 21% higher absolute risk of ICU/MV (RD 0.21, 95% CI 0.19-0.24; RR 1.49, 95% CI 1.43-1.56) and a 5% higher absolute risk of mortality (RD 0.05, 95% CI 0.03-0.07; RR 1.40, 95% CI 1.24-1.57), with adjustment for age, sex, and race or ethnicity. Compared with T2DM, T1DM was associated with a 9% higher absolute risk of ICU/MV (RD 0.09, 95% CI 0.07-0.12; RR 1.17, 95% CI 1.12-1.22), but no difference in mortality (RD 0.00, 95% CI -0.02 to 0.02; RR 1.00, 95% CI 0.89-1.13). After adjustment for diabetic ketoacidosis (DKA) occurring before or at COVID-19 diagnosis, patients with T1DM no longer had increased risk of ICU/MV (RD 0.01, 95% CI -0.01 to 0.03) and had lower mortality (RD -0.03, 95% CI -0.05 to -0.01) in comparisons with patients with T2DM. CONCLUSIONS: Patients with T1DM hospitalized for COVID-19 are at higher risk for severe outcomes than those without diabetes. Higher risk of ICU/MV in patients with T1DM than in patients with T2DM was largely accounted for by the presence of DKA. These findings might further guide recommendations related to diabetes management and the prevention of COVID-19.
引用
- Barrett CE, Park J, Kompaniyets L, et al. Intensive Care Unit Admission, Mechanical Ventilation, and Mortality Among Patients With Type 1 Diabetes Hospitalized for COVID-19 in the U.S. Diabetes Care. 2021. PMID: 34158365. doi:10.2337/dc21-0604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。